Danaher Corporation (DHR): Rep. John R. Curtis (UT03) disclosed a sale $1K–$15K

$1,001–$15,000

Reported range · official band, not an exact amount

11 days

Disclosure lag

Traded

Dec 4, 2023

Disclosed

Dec 15, 2023

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Sep 13, 2023CongressDisclosed purchase of DHR — reported range $15,001 - $50,000
2. Sep 26, 2023CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
3. Oct 24, 2023CongressDisclosed sale of DHR — reported range $1,001 - $15,000
4. Dec 4, 2023 · this disclosureCongressDisclosed sale of DHR — reported range $1,001 - $15,000

What came next

1. Dec 18, 2023FDAFDA device clearance: Access hsTnI
2. Dec 19, 2023FDARecall: Beckman Coulter DxU 850m/840m Microscopy Analyzers, Part Numbers: C49513, C76947
3. Dec 19, 2023FDARecall: iQ200 Series Urine Microscopy Analyzers, Part Numbers: a) 700-3320, b) 700-3370, c) 700-3345, d) 700-3347, e) C10683, f) 700-3375, g) 700-3325, h) C10684
4. Dec 19, 2023FDARecall: iQ Waste Well Adapter, Part Number: 700-3393
5. Dec 19, 2023FDARecall: REV 2 Flowcell Capsule Spare, Part Number: C04154
6. Jan 3, 2024FDARecall: Beckman Coulter DxI 9000 Access Immunoassay Analyzer, catalog number C11137; in-vitro diagnostic instrument
7. Feb 7, 2024FDARecall: Access Substrate, REF 81906, For use with the Access Immunoassay Systems
8. Feb 8, 2024FDAFDA device clearance: Access SHBG
9. Feb 8, 2024FDARecall: Access Total T4, REF 33800, IVD, thyroxine reagent assay.
10. Feb 16, 2024FDAFDA device clearance: Access CK-MB
11. Feb 29, 2024FDARecall: Beckman Coulter DxI 9000 Access Immunoassay Analyzer is a discrete photometric chemistry analyzer for clinical use. It is an in-vitro diagnostic device used fo…
12. Mar 1, 2024FDAFDA device clearance: Access Intact PTH
13. Mar 5, 2024FDARecall: DxI 9000 Access Immunoassay Analyzer, REF C11137, vitro diagnostic device used for the quantitative, semi-quantitative, or qualitative determination of various…
14. Mar 6, 2024FDAFDA device clearance: Access Free T4
15. Mar 20, 2024FDAFDA device clearance: Access Ferritin

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Danaher Corporation

For Danaher Corporation, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DHR page.

Other recent filings by Rep. John R. Curtis (UT03)

• House Clerk periodic transaction report at BlackRock (BLK)Dec 15, 2023
• House Clerk periodic transaction report at Abbott Laboratories (ABT)Dec 15, 2023
• House Clerk periodic transaction report at Adobe (ADBE)Dec 15, 2023
• House Clerk periodic transaction report at AMD (AMD)Dec 15, 2023
• House Clerk periodic transaction report at Alphabet (GOOGL)Dec 15, 2023

The full history of Rep. John R. Curtis (UT03) is on the profile page.

How this filing works

• The STOCK Act

Other disclosures at Danaher Corporation

• SEC Form 144Nov 10, 2026
• SEC Form 4Nov 10, 2026
• SEC Form 4Nov 10, 2026
• SEC Form 144Nov 9, 2026
• SEC Form 144Nov 9, 2026
• SEC Form 144Nov 9, 2026

Everything OQRO holds on this company is on its DHR page.